Kirkland Advises H.I.G. Capital and Aspire Pharma on Acquisition of Morningside Pharmaceuticals
Kirkland & Ellis is advising H.I.G. Capital and its portfolio company, Aspire Pharma, on the acquisition of Morningside Pharmaceuticals. Morningside Pharmaceuticals is a manufacturer, wholesaler, distributor and supplier of generic and branded medicines and healthcare products to the UK and international export markets.
The Kirkland team was led by corporate partners Roger Johnson, Tom McCarthy and Adrian Duncan; debt finance partners Neel Sachdev and Leon Daoud; technology & IP transactions partner John Patten and associate Colin Russell; tax partner Timothy Lowe; and antitrust partner Sally Evans.
